Analystreport

Biohaven Ltd. (NYSE: BHVN) had its price target raised by analysts at TD Cowen from $35.00 to $55.00. They now have an "outperform" rating on the stock.

Biohaven Ltd. Common Shares  (BHVN) 
Last biohaven ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com